Novosteo
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $6.1M
Investors
- 5
About Novosteo
Novosteo Inc.Founded in 2017 in West Lafayette, Indiana, Novosteo Inc. develops solutions for bone health.Novosteo specializes in innovative solutions within the health and wellness sector, primarily focusing on products designed to enhance bone health and overall musculoskeletal function. Their core offerings include a range of dietary supplements that utilize advanced formulations aimed at improving calcium absorption and promoting bone density. These products cater to end users at risk of osteoporosis and other bone-related conditions, including older adults and individuals with specific nutritional needs. Novosteo's products have been launched within the last few years and are targeted at health-conscious consumers across North America and Europe, where market demand for preventive health solutions is on the rise.Novosteo generates revenue through a direct-to-consumer model as well as partnerships with health and wellness retailers. The company structures its transactions primarily through subscription plans that allow customers to receive regular shipments of their flagship dietary supplements. These subscription services provide a steady revenue stream while ensuring customer retention through convenience and tailored product delivery. Additionally, Novosteo collaborates with various healthcare practitioners, who recommend its products to patients, thereby expanding its market reach.Following the acquisition of Novosteo Inc. by Cortexyme, Inc. in May 2022, the focus will be on expanding the drug development pipeline into rare disease indications with the addition of NOV004, a bone-targeting molecule designed to accelerate fracture repair, including in patients with osteogenesis imperfecta. Plans are underway to launch new products designed for enhanced bone health, targeting health-conscious markets in North America and Europe by mid-2023.
Who invested in Novosteo
5 investors across 2 rounds
See all investors in Novosteo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novosteo
Who invested in Novosteo?
Novosteo has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novosteo raised?
Novosteo has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Novosteo last raise money?
Novosteo's most recent round on record is a Series A, in Dec 2020.
What does Novosteo do?
Novosteo is a pharmaceuticals company.
Where is Novosteo headquartered?
Novosteo is headquartered in West Lafayette, US.
Which VCs invest in companies like Novosteo?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Novosteo's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Novosteo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.